HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Main » Latest Breaking News (Forum) » FDA affirms refusal to re... » Reply #1

Response to Judi Lynn (Original post)

Thu Apr 20, 2017, 09:16 PM

1. Here's an article tickle from Buzzfeed with more info

After a nearly two-year standoff between death penalty states and the federal government, the Food and Drug Administration formally blocked shipments of thousands of illegal execution drugs on their way to Texas and Arizona. The move sets up a potential legal battle between death penalty states and the Trump administration.

In 2015, Texas, Arizona, and Nebraska each purchased 1,000 vials of sodium thiopental, an anesthetic now-banned in the United States. The supplier, a man in India named Chris Harris, claimed to be a manufacturer, but a BuzzFeed News investigation raised questions about his claims.

A facility he lists with the DEA turned out to be a former apartment he left owing rent on. The facility he registered with the FDA is a small office space he rents; a secretary at the building said manufacturing couldn’t be done there.

States, desperate to obtain execution drugs, have turned to Harris a handful of times over the past several years. Each time, Harris convinces the states that the legal problems with the drugs he sells are solved; They’ve never actually been used in executions, but he’s made more than $100,000 from the sales.


Much more at link: https://www.buzzfeed.com/chrismcdaniel/trump-administration-blocks-shipment-of-illegal-execution?utm_term=.nqxlZ23P4#.rkdeLxMZw

Reply to this post

Back to OP Alert abuse Link to post in-thread

Always highlight: 10 newest replies | Replies posted after I mark a forum
Replies to this discussion thread
Arrow 5 replies Author Time Post
Judi Lynn Apr 2017 OP
LineNew Reply Here's an article tickle from Buzzfeed with more info
tammywammy Apr 2017 #1
Judi Lynn Apr 2017 #2
ret5hd Apr 2017 #3
truthisfreedom Apr 2017 #4
Kathy M Apr 2017 #5
Please login to view edit histories.